Classification of Adenosine Receptors in Peripheral Tissues

  • David M. Paton


The numerous actions of adenosine on peripheral tissues have been extensively studied in the past 20 years. Most, if not all, of these actions apparently result from activation of discrete receptors by adenosine. The two main current classification systems for adenosine receptors are detailed and discussed elsewhere in this volume by Burnstock and Buckley (Chapter 11) and by Schwabe (Chapter 13) and have been reviewed by a number of authors including Londos et al. (1981), Stone (1982), and Daly et al. (1981). Consequently, they will not be further detailed in this review. The emphasis will be rather on a number of practical issues that arise in the classification of adenosine receptors in peripheral tissues and on a number of outstanding questions related to the activation of such receptors by adenosine.


Adenosine Receptor Adenine Nucleotide Adenosine Deaminase Purinergic Receptor Bathing Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Broadley, K. J., Broome, S., and Paton, D. M., 1985. Hypothermia-induced supersensitivity to adenosine for responses mediated via A1 receptors, but not A2 receptors. Br. J. Pharmacol., in press.Google Scholar
  2. Brown, C. M., and Burnstock, G. 1981. The structural conformation of the polyphosphate chain of the ATP molecule is critical for its promotion of prostaglandin biosynthesis. Europ. J. Pharmacol. 69: 81–86.CrossRefGoogle Scholar
  3. Bruns, R. F. 1980a. Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol., 55: 673–691.CrossRefGoogle Scholar
  4. Bruns, R. F. 1980b. Adenosine receptor activation by adenosine nucleotides requires conversion of the nucleotides to adenosine. Naunyn Schmiedebergs Arch. Pharmacol., 315: 5–13.PubMedCrossRefGoogle Scholar
  5. Bruns, R. F., Daly, J. W., and Snyder, S. H. 1983. Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists. Proc. Natl. Acad. Sci. USA, 80: 201–2080.Google Scholar
  6. Burnstock, G. 1978. A basis for distinguishing two types of purinergic receptors. In: Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, pp. 107–118. Ed. by Bolis, L., and Straub, R. W. Raven Press, New York.Google Scholar
  7. Burnstock, G., Cusack, N. J., Hills, J. M., MacKenzie, I, and Meghji, P. 1983. Studies on the stereoselectivity of the P2-purinoceptor. Br. J. Pharmacol., 79: 907–913.Google Scholar
  8. Collis, M. G., and Pettinger, S. J. 1983. Can ATP stimulate Pi-receptors in guinea-pig atrium without conversion to adenosine. Europ. J. Pharmacol. 81: 521–529.CrossRefGoogle Scholar
  9. Cusack, N. J., and Planker, M. 1979. Relaxation of isolated taenia coli of guinea-pig by enantiomers of 2-azido analogues of adenosine and adenine nucleotides. Br. J. Pharmacol., 67: 153–158.Google Scholar
  10. Daly, J. W., Bruns, R. F., and Snyder, S. H. 1981. Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci., 25: 2083–2097.CrossRefGoogle Scholar
  11. Dowdle, E. B., and Maske, R. 1980. The effects of dipyridamole on the guinea-pig ileal longitudinal muscle-myenteric plexus preparation. Br. J. Pharmacol., 71: 235–244.PubMedGoogle Scholar
  12. Furchgott, R. F. 1972. The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Handbook of Pharmacology, Catecholamines, Volume 33, pp. 283–335. Ed. by Blashko H., and Muscholl, E. Springer, Berlin.Google Scholar
  13. Kasakov, L., and Burnstock, G. 1983. The use of the slowly degradable analog, a,p-methyleneATP, to produce desensitisation of the P2-purinoceptor effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Europ. J. Pharmacol., 86: 291–294.CrossRefGoogle Scholar
  14. Kusachi, S., Thompson, R. D., and Olsson, R. A. 1983. Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J. Pharmacol. Exp. Ther., 227: 316–321.Google Scholar
  15. Londos, C., Wolff, J., and Cooper, D. M. F. 1981. Adenosine as regulator of adenylate cyclase. In: Purinergic Receptors, Receptors and Recognition, Series B, Volume 12, pp. 289–323. Ed. by Burnstock, G. Chapman and Hall, London.Google Scholar
  16. Maguire, M. H., and Satchell, D. G. 1979. The contribution of adenosine to the inhibitory actions of adenine nucleotides on the guinea-pig taenia coli: Studies with phosphate-modified adenine nucleotide analogs and dipyridamole. J. Pharmacol. Exp. Ther., 211: 626–631.Google Scholar
  17. Meldrum, L. A., and Burnstock, G. 1983. Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea pig vas deferens. Europ. J. Pharmacol., 92: 161–163.CrossRefGoogle Scholar
  18. Moody, C. J., and Burnstock, G. 1982. Evidence for the presence of Pi-purinoceptors on cholinergic nerve terminals in the guinea-pig ileum. Europ. J. Pharmacol., 77: 1–9.CrossRefGoogle Scholar
  19. Moody, C. J., Meghji, P., and Burnstock, G. 1984. Stimulation of Pi-purinoceptors by ATP depends partly on its conversion to AMP and adenosine and partly on direct action. Europ. J. Pharmacol., 97: 55–65.CrossRefGoogle Scholar
  20. Muller, M. J., and Paton, D. M. 1979. Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination. Naunyn-Schmie deb ergs. Arch. Pharmacol., 306: 23–28.Google Scholar
  21. Paton, D. M. 1981. Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: Evidence for action on Ai receptors. J. Auton. Pharmacol., 7: 287–290.CrossRefGoogle Scholar
  22. Paton, D. M., and Webster, D. R. 1984. On the classification of adenosine and purinergic receptors in rat atria and in peripheral adrenergic and cholinergic nerves. In: Neuronal and Extraneuronal Events in Autonomic Pharmacology, pp. 193–204. Ed. by Fleming, W. W., Langer, S. Z., Graefe, K. H., and Weiner, N. Raven Press, New York.Google Scholar
  23. Schwabe, U., Lenschow, V., Ukena, D., Ferry, D. R., and Glossman, H. 1982. [125I]N6-p-Hydrox- yphenylisopropyl-adenosine, a new ligand for R adenosine receptors. Naunyn-Schmiedebergs Arch. Pharmacol., 321: 84–87.Google Scholar
  24. Silver, P. J., Walus, K., and DiSalvo, J. 1984. Adenosine mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary artery smooth muscle. J. Pharmacol. Exp. Ther., 228: 342–347.Google Scholar
  25. Stone, T. W. 1982. Cell-membrane receptors for purines. Biosci. Rev., 2: 77–90.CrossRefGoogle Scholar
  26. Taylor, D. A., Wiese, S., Faison, E. P., and Yarbrough, G. G. 1983. Pharmacological characterization of purinergic receptors in the rat vas deferens. J. Pharmacol. Exp. Ther., 224: 40–45.PubMedGoogle Scholar
  27. Willemot, J., and Paton, D. M. 1981. Metabolism and presynaptic nucleotides in rat vas deferens. Naunyn-Schmiedebergs Arch. Pharmacol., 317: 110–114.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • David M. Paton
    • 1
  1. 1.Department of Pharmacology and Clinical PharmacologyUniversity of AucklandAucklandNew Zealand

Personalised recommendations